The Latest Cardiac and Vascular News
BOZEMAN, Mont., July 31, 2020 /PRNewswire/ — Pulsara, the leading telehealth and communication platform that connects teams across organizations, announced today that the company has been named a compatible vendor within the American Heart Association Get With The Guidelines® program. This premier AHA program assists hospitals in measuring and improving cardiovascular disease and […]
LAGUNA HILLS, Calif., Aug. 3, 2020 /PRNewswire/ — Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS™), today announced successful pre-clinical results demonstrating their existing cryoablation catheter is also capable of ablating the tissue through pulsed field ablation (PFA) delivered […]
Amersham, UK, Minnesota, USA, and Melbourne, Australia — 30 July 2020 — GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVertTM contrast minimization devices, […]
IRVINE, Calif.–(BUSINESS WIRE)–Transforming the treatment of aortic disorders, Endologix® Inc. (OTC: ELGXQ) (“Endologix” or the “Company”), today announced the first commercial implant and the U.S. commercial release of its recently FDA-approved ALTO® endograft for the treatment of abdominal aortic aneurysms (AAA). “ALTO represents a differentiation from traditional endovascular aneurysm repair (EVAR) and, […]
SHANGHAI–(BUSINESS WIRE)–BLUE SAIL MEDICAL CO., LTD. (Blue Sail) opened its Blue Sail Shanghai Innovation Center (BSIC) in July 2020 at ATLATL Innovation Center, which built the customized GMP facility after a 10-month effort. Blue Sail is the world’s largest vinyl glove enterprise (Shenzhen SE code: 002382). Blue Sail entered the […]
Study conducted at 109 hospitals with oversight by 10 Japanese professional societies, including Japanese Circulation Society TOKYO–(BUSINESS WIRE)–A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump finds use of Impella is associated with a 77% survival rate at 30 days in AMI cardiogenic shock patients. The historic […]
– Empagliflozin significantly reduced the risk of cardiovascular death or hospitalization for heart failure versus placebo in the EMPEROR-Reduced heart failure trial. The study evaluated adults with heart failure with reduced ejection fraction – Treatment of heart failure is an important unmet need with over half of those diagnosed dying within five […]
HITRUST CSF Certification validates Ontrak is committed to meeting key regulations and protecting sensitive information SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the company’s data pipeline system, eOntrak Case Management System and supporting technology infrastructure have […]
Company expands portfolio of solutions with groundbreaking insertable cardiac monitor system MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced a sales agent […]
EDEN PRAIRIE, Minn., July 30, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with SysteMedic Ltd., covering Israel and Palestine, representing the second distribution partnership in the Middle East region. Ultrafiltration therapy is now available in 16 countries outside the U.S. Ninety […]
